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Abstract To probe the limiting nodes in the chaperoning
network which maintains cellular proteostasis, we expres-
sed a dominant negative mutant of heat shock factor 1
(dnHSF1), the regulator of the cytoplasmic proteotoxic
stress response. Microarray analysis of non-stressed
dnHSF1 cells showed a two- or more fold decrease in
the transcript level of 10 genes, amongst which are the
(co-)chaperone genes HSP90AA1, HSPA6, DNAJB1 and
HSPB1. Glucocorticoid signaling, which requires the
Hsp70 and the Hsp90 folding machines, was severely
impaired by dnHSF1, but fully rescued by expression of
DNAJA1 or DNAJB1, and partially by ST13. Expression
of DNAJB6, DNAJB8, HSPA1A, HSPB1, HSPB8, or
STIP1 had no effect while HSP90AA1 even inhibited.
PTGES3 (p23) inhibited only in control cells. Our results
suggest that the DNAJ co-chaperones in particular become
limiting in a depleted chaperoning network. Our results
also suggest a difference between the transcriptomes of
cells lacking HSF1 and cells expressing dnHSF1.
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Introduction
All cells contain an extensive network of chaperones which
together maintain proteostasis, i.e. this network aids in the
folding of the primary peptide chain, the refolding of
unfolding proteins and the removal of misfolded proteins
(for reviews, see [1–8]). Two of the major nodes in the
network are the Hsp70 and Hsp90 folding machines. At the
core of these machines are Hsp90 and Hsp70, the proteins
that promote folding; the activity and substrate specificity
is controlled by a number of co-factors and co-chaperones.
For Hsp70 it is the DNAJ (Hsp40) proteins that determine
substrate specificity. DNAJs also stimulate ATP hydrolysis
by Hsp70. The human genome contains over 40 DNAJ
genes [9–11]. Some of these are highly tissue specific,
others may be dedicated to a particular substrate or coop-
erate only with a specific Hsp70 and some may be
redundant [12]. The diversity of DNAJs does show that
these are important determinants of the activity and spec-
ificity of the Hsp70 folding machine.
The chaperoning capacity of the cell is enhanced by
additional chaperone synthesis as part of a proteotoxic
stress response, either the heat shock response in the case
of cytoplasmic stress or the unfolded protein response in
the case of ER stress. That an increase in chaperones is
required to combat proteotoxic stress suggests that under
normal conditions the chaperone capacity of a cell is lim-
iting. Indeed, exogenous expression of aggregation-prone
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proteins, such as proteins with an expanded glutamine tract
(polyQ), is toxic unless chaperones are also overexpressed
[13–17]. Cytoplasmic proteotoxic stress signals to heat
shock factor 1 (HSF1), which then activates the transcrip-
tion of a number of genes encoding a variety of
chaperones, together known as the heat shock proteins. In
the absence of stress, HSF1 is generally believed to be kept
inactive in the cell by direct interaction with Hsp90, p23
and immunophilins (for reviews, see [18–20]). HSF1 null
mice show the expected stress-related phenotypes, such as
a complete lack of the heat shock response and the inability
to develop thermotolerance. However, they also suffer
from neuronal, developmental and germ cell defects [21–
26], which cannot be directly linked to the heat shock
response and which strongly suggests that HSF1 also
regulates gene expression under non-stress conditions.
Microarray analysis resulted in the identification of 49
genes (19 related to immune response) that are expressed at
reduced levels in HSF1 null fibroblasts compared with
wild-type cells cultured under physiological conditions.
The immune response of HSF1 null mice was shown to be
severely impaired [27]. More recently, direct evidence for
the stress-independent regulation of genes by HSF1 was
provided in the cass of the multi-drug resistance gene 1
[28] and the IL-6 gene [29]. Furthermore, HSF1 inhibits
heregulin-induced transcription in breast carcinoma cells
[30].
A number of studies have shown that the quality of the
heat shock response diminishes with aging [31–37], a
decrease that may be the result of a decrease in the activity
of the deacetylase SIRT1 [38]. Senescence of cultured
human fibroblasts is accompanied with a diminishing heat
shock response and a reduction in the affinity of HSF1 for
the heat shock element (HSE; [34]). Aging-related failure
of HSF1 will interfere with an organism’s ability to combat
cellular stress and increase the susceptibility to protein
folding disease [6, 8, 13, 14, 39–41]. Moreover, with
accumulating evidence showing that HSF1 also regulates
gene expression under non-stress conditions (see above),
its decline may already cause phenotypic defects in the
absence of exogenous stress [3, 4].
Here, we have used a dominant negative HSF1 mutant
to inhibit HSF1 activity. As expected, a number of chap-
erone and co-chaperone genes were downregulated by
dnHSF1. To test which (co-)chaperone is limiting in
dnHSF1-expressing and thus chaperone-depleted cells, we
used the glucorticoid response to probe the chaperoning
network. Maturation of the steroid hormone receptor is
known to be controlled by both the Hsp70 and the Hsp90
folding machinery (for review, see [42]) and augmenting
the chaperone network by either stress [43] or expression
of a constitutively active HSF1 mutant [44] potentiates
the glucocorticoid response. We show here that it is,
unexpectedly, primarily the DNAJ (Hsp40) proteins which
become limiting when the chaperoning network is
depleted.
Materials and methods
Recombinant DNA constructs
Oligonucleotides that were used to generate recombinant
DNA constructs are listed in Table 1. Plasmid pLmHSF1SN
that contains the code for the HSF448 mutant was kindly
donated by Dr. Wang [45]. The 1.36-kb XhoI fragment of
pLmHSF1SN was cloned into pcDNA5-FRT/TO (Invitro-
gen), resulting in plasmid pcDNA5-HSF448. The code for
the HSF1 mutant HSF379 was PCR amplified from
pLmHSF1SN using the HSF379 primer set and cloned into
the HindIII and XhoI sites of pcDNA5-FRT/TO, yielding
plasmid pcDNA5-HSF379 (dnHSF1). The promoter con-
structs pGL3-HspB1 (-685/?36), pGL3-DnaJA1 (-464/
?167), pGL3-DnaJB1 (-508/?38), pGL3-Hsp90AA1
(-188/?18), pGL3-ST13 (-400/?141), pGL3-STIP1
(-1264/?145), pGL3-PTGES3 (-1108/?104), pGL3-
RMB23 (-1265/?189), pGL3-PMVK (-1183/?147),
pGL3-BiP (-2742/?202), pGL3-CHOP (-936/?2), and
pGL3-HSPA1A (-313/?196) were made by PCR ampli-
fying the promoter fragments from human genomic DNA
using the respective ‘‘prom’’ primer sets and cloning the
fragments into pGL3-Basic (Promega). The expression
plasmids pcDNA5-HSPB1, pcDNA5-HSPB8, pcDNA5-
ST13, pcDNA5-STIP1, and pcDNA5-PTGES3 were made
by PCR amplifying the cDNAs from HEK293 RNA using
the respective ‘‘exp’’ primer sets and cloning the cDNAs into
pcDNA5-FRT/TO. Expression plasmids pcDNA5-V5-
DnaJA1, pcDNA5-V5-DnaJB1, pcDNA5-V5-DnaJB6, and
pcDNA5-V5-DnaJB8 were kindly donated by J. Hageman
(University of Groningen, The Netherlands; [46]). Expres-
sion construct pCMV-SPORT6-Hsp90AA1 was obtained
from Imagenes (http://www.imagenes-bio.de). The
Hsp90AA1 coding sequence was completed at the 50 end by
inserting the corresponding fragment PCR amplified from
human cDNA SacII-MscI. Plasmid pOTB7-STIP1 was
obtained from Imagenes. The EcoRI (blunt)—XhoI frag-
ment of pOTB7-STIP1 was cloned into the HindIII (blunt)
and XhoI sites of pcDNA5-FRT/TO, resulting in plasmid
pcDNA5-STIP1. The glucocorticoid-responsive reporter
plasmid pGRE-Luc was made by annealing the GRE primer
set and cloning the double stranded oligo into the NheI and
BglII sites of pGL3-promoter (Promega). The Drosophila
melanogaster Hsp70-luciferase reporter construct pHL and
the Hsp70 expression construct were described earlier [47].
Plasmid pRL-CMV was obtained from Promega. All plas-
mid constructs were sequence verified.
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Tissue culture, transfections, and reporter gene assays
Flp-In T-REx-293 cells (Invitrogen) were manipulated
according to the manufacturer’s instructions using the
T-REx system (Invitrogen) to generate the stable cell lines
HEK-HSF448, HEK-HSF379 and HEK-cDNA5 that carry
a single copy of the tetracycline-inducible plasmids
pcDNA5-HSF448, pcDNA5-HSF379, and pcDNA5-FRT/
TO, respectively. The cells were cultured at 37C/5% CO2
in high glucose DMEM medium supplemented with 10%
fetal calf serum and 100 U/ml penicillin and 100 lg/ml
streptomycin. Blasticidin (1.65 lg/ml; Invitrogen) and
100 lg/ml hygromycin were also added to the culture
medium during maintenance of the cell lines, but were
omitted during experiments. Transient transfections were
performed using FuGENE-6 (Roche) according to the
manufacturer’s instructions. Cells were seeded on 24-well
plates and on the next day transfected with *0.2 lg
plasmid per well. For testing the heat shock response in
stable HEK293 cell lines, cells were transfected with
Table 1 Oligonucleotides that
were used to generate
recombinant DNA constructs
Oligo name Oligo sequence (50 ? 30)
HSF379-for agctaagcttaccatggatctgcccgtgggcc
HSF379-rev agctctcgagctacaggcaggctacgctgaggc
PMVKprom-for agctaagcttactcaggtaaaacaggagatgtg
PMVKprom-rev agctccatggccaaacagatatggggagaaaag
RBM23prom-for agctctcgagtatccaagacccaaaggggcc
RBM23prom-rev agctccatggcagttccgggtccccgcag
STIP1prom-for agctaagcttgtggggcaggtggaattaaag
STIP1prom-rev agctccatggcgcagcgcggtccggaacc
HSPB1prom-for agtcgacaggcatgcaccaccatgcccagc
HSPB1prom-rev accatggtggctgactctgctctggacgtctg
ST13prom-for agctaagcttccccttccggcggaggcg
ST13prom-rev agctccatggtagggaggtggtgg
PTGES3prom-for agctaagcttaataccttagtgcttattatgaagc
PTGES3prom-rev agctccatggtgaacggggcagggggacg
DNAJA1prom-for agtcgaccacgcgtgaaaaacagcaagac
DNAJA1prom-rev accatggtggctgaggccggtgtgtgaggga
DNAJB1prom-for aagtcgaccagacacaggttaggtagttcgtcc
DNAJB1prom-rev accatggccccctcctgcggcccgccga
CHOPprom-for tgagctctgtcacccaggctggagtgc
CHOPprom-rev tagatctctgacctcgggagcgcctggctg
BiPprom-for tctcgaggtatttttagtagagactgggcac
BiPprom-rev accatggtgccagccagttgggcagcag
HSP90prom-for agctaagcttgcgcaggcgctgttcctgg
HSP90prom-rev agctccatggcgcccggaggccacaccc
HSPA1Aprom-for aagatcttgaagcgcaggcggtcagca
HSPA1Aprom-rev aaagcttccggttccctgctctctgtc
HSP90AA1exp-for tccgcggtcacttagccaagatgcctg
HSP90AA1exp-rev tggccaatcatagagatatctgcacc
HSPB1exp-for agctaagcttaccatgaccgagcgccgcgtc
HSPB1exp-rev agctctcgagttacttggcggcagtctcatcg
HSPB8exp-for agctaagcttaccatggctgacggtcagatg
HSPB8exp-rev agctctcgagtcaggtacaggtgacttcctggct
ST13exp-for agctaagcttaccatggacccccgcaaagtg
ST13exp-rev agctaagcttaccatggacccccgcaaagtg
PTGES3exp-for agctggatccaccatgcagcctgcttctgcaaagtg
PTGES3exp-rev agctctcgagttactccagatctggcattttttc
GRE-up ctagcggtacattttgttctagaacaaaatgtaccggtacattttgttct
GRE-low gatctagaacaaaatgtaccggtacattttgttctagaacaaaatgtacc
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160 ng pHL, and 40 ng pCMV-RL. At 48 h after trans-
fection, cells were either left at 37C/5% CO2 (control) or
incubated at 45C for 300 (heat shock). After 6 h recovery
at 37C/5% CO2, cells were harvested for reporter gene
analysis. For analysis of promoter activities, cells were
transfected with a mixture of 160 ng luciferase reporter
plasmid and 40 ng pbactin-b-galactosidase or pCMV-RL
per well. For testing glucocorticoid responsiveness, the
culture medium of the cells was first replaced with medium
supplemented with 10% steroid-free fetal calf serum
(Hyclone), and then the cells were transfected with a
mixture of 150 ng pGRE-Luc and 50 ng pbactin-b-galac-
tosidase per well. At 24 h after transfection, the culture
medium was replaced with medium containing varying
concentrations of dexamethasone (Centrafarm). At 48 h
after transfection, cells were lysed in 200 ll reporter lysis
mix (25 mM Bicine, 0.05% Tween 20, 0.05% Tween 80)
for 10 min. For the b-galactosidase assay, 40 ll cell lysate
was mixed with 100 ll Galacton solution (100 mM
Na-phosphate pH 8.2, 10 mM MgCl2, 1% Galacton-Plus;
Tropix). After 30 min incubation at room temperature,
150 ll accelerator II (Tropix) was added and luminescence
was measured with the Lumat LB 9507 tube luminometer
(Berthold). For the luciferase assay, 40 ll cell lysate was
mixed with 50 ll luciferin solution and luminescence was
again measured with the Lumat luminometer. All reporter
gene assays were performed in triplicate.
RNA isolation and microarray analysis
HEK-HSF379 or HEK-cDNA5 cells were either left
untreated or treated with doxycyclin for 48 h. Total RNA
was isolated using Trizol according to the manufacturer’s
instructions (Invitrogen) and copied into Cy3-labeled
(untreated cells) or Cy5-labeled (doxycyclin-treated cells)
cRNA using the Agilent Low RNA Input Linear Amp Kit
PLUS, or the reverse for the repeat array. Labeled cRNA
samples were hybridized to an Agilent Whole Human
Genome Microarray Kit (4 9 44K). The arrays were
scanned using an Agilent Microarray Scanner. Image
analysis and feature extraction were done with Feature
Extraction (version 9.5.1, Agilent). Only genes that passed
the GeneSpringGX standard quality control criteria (free
trial available at http://www.genespring.com) were inclu-
ded in the analysis. We used a cut-off level of twofold
changed expression (average signal intensity across the
array) and an arbitrarily chosen signal cut-off of [50.
Western blot analysis
Cell pellets were homogenized in buffer containing 50 mM
Tris–HCl pH 7.5, 150 mM NaCl, 1% Triton X-100,
100 mM NaF, 20 mM Na4P2O7, 1 mM PMSF and protease
inhibitors (Complete Mini; Roche). Then 49 sample buffer
(200 mM Tris–HCl 6.8, 20% b-mercaptoethanol, 8% SDS,
40% Glycerol and 0.4% Bromophenolblue) was added and
the lysates were incubated at 95C for 5 min. For detection
of eIF2a phosphorylation, samples were prepared as
described [48]. Protein samples were separated in 12%
polyacrylamide gels and transferred to nitrocellulose
transfer membrane (Protran) using a Bio-Rad Mini-
PROTEAN II Electrophoresis cell according to the
manufacturer’s instructions. For western blot analysis,
polyclonal HSF1 antibody (SPA-901; Stressgen) was used
at a 1: 15,000 dilution, Hsp70 antibody 4G4 (ab5444;
Abcam) was used at a 1:5,000 dilution, polyclonal DnaJB1
antibody (anti-Hsp40; SPA-400; Stressgen) at a 1:10,000
dilution, monoclonal Hsp90 antibody (610418, BD Bio-
sciences) at a 1:1,000 dilution, HSPB1 antibody, obtained
from Dr. A. Zantema, at a dilution of 1:400, monoclonal
eIF2a antibody was at a 1:500 dilution, polyclonal phos-
phorylated eIF2a antibody (E2152; Sigma) was used at a
1:1,000 dilution, monoclonal V5 antibody (R96025;
Invitrogen) was used at a 1:5,000 dilution, polyclonal ST13
antibody (ab13490; Abcam) at a 1:1,000 dilution, poly-
clonal STIP1 antibody (ab65046; Abcam) a 1:1,000
dilution, monoclonal p23 antibody (ab2814; Abcam) at a
1:1,000 dilution, polyclonal HSPB8 antibody, obtained
from Dr. W. Boelens, at a dilution of 1:1,000, and mono-
clonal b-actin antibody (AC-15, Sigma-Aldrich) at a
dilution of 1:5,000. Blots were incubated with fluorescent
secondary antibodies IRDye 800 CW conjugated goat
(polyclonal) Anti-Rabbit IgG and IRDye
TM
680 conjugated
goat (polyclonal) Anti-Mouse IgG. (926-32211 and
926-32220, respectively; LI-COR Biosciences) according
to the manufacturer’s instructions and scanned using a
LI-COR Odyssey infrared scanner. Signals were quantified
using Odyssey version 2.1 software.
Results
Dominant negative HSF1 mutants
To block HSF1 signaling in human HEK293 cells, we
decided to use a dominant negative mutant reasoning that,
given the interaction of HSF1 with other cellular compo-
nents, the effect of a transcriptionally inactive mutant could
well be different from the effect of HSF1 being completely
absent. Two dominant negative HSF1 mutants containing,
respectively, the first 379 (HSF379) and first 448 (HSF448)
amino acids have been described (reviewed by [49]).
HSF379 lacks both the potent trans-activation domain at
the extreme C-terminus and the weaker, more N-terminal,
trans-activation domain, whereas HSF448 still has the
weak trans-activation domain. The heat shock-mediated
4038 L. Heldens et al.
induction of endogenous Hsp70 was completely abolished
by HSF379, showing its potent dominant-negative activity
(Fig. 1). Surprisingly, HSF448 was a very poor inhibitor of
heat shock-mediated induction of Hsp70 (data not shown).
Moreover, HSF448 caused a significant increase in the
basal expression of Hsp70 (Fig. 1). Since this observation
was in conflict with earlier data showing the dominant-
negative activity of HSF448 [45], we tested the activities of
both HSF1 mutants in a luciferase reporter gene assay. As
expected, HSF379 completely inhibited the heat shock-
mediated induction of the D. melanogaster Hsp70
promoter (Fig. 2). In the experiments reported below,
HSF379 was used to inhibit HSF1 activity and will be
referred to as dnHSF1.
Transcriptome changes in the presence of dnHSF1
If HSF1 plays a role even in the absence of exogenous
stress, then exogenous expression of a dominant-negative
HSF1 mutant in unstressed cells should change the tran-
scriptome. We therefore compared the transcriptomes of
HEK cells with or without doxycycline and with or without
dnHSF1 using a two-color 44K Agilent Human Expression
Profile Array. The transcripts of only 10 genes showed a
more than twofold lower level in the presence of dnHSF1
(Table 2 in bold, and Table 3). Four of these, namely
HSPA6 (hsp70B0), HSP90AA1 (Hsp90), DNAJB1
(Hsp40), and HSPB1 (Hsp27), encode chaperones (Table 2
in bold). The steady state level of the corresponding pro-
teins was also reduced in dnHSF1 expressing cells (Fig. 3;
note that the HSPA6 mRNA level is very low in non-
stressed HEK293 cells; [50]). Surprisingly, there was a
distinct difference between dnHSF1 expressing cells and
mouse embryonic fibroblasts lacking HSF1: the hsf-/hsf-
MEFs contain wild type levels of Hsp90 and DNAJB1.
The levels of the transcripts of a number of other
chaperone genes did not quite meet the ‘‘twofold’’ lower in
the presence of dnHSF1 cut-off, but did come close
(AHSA2, for example; Table 2). To test whether HSF
responsiveness is a general property of genes encoding
(co-)chaperones, we looked at the response of all known
members of the HSP gene families (HSPH, HSPA, DNAJ,
and HSPB) as well as other known (co-)chaperones coding
genes expressed in HEK 293 cells (Table 2). Of the HSPA
(Hsp70) genes, only HSPA6 responded strongly to
dnHSF1. Similarly, very few members of the large DNAJ
(Hsp40) family were downregulated by HSF1. This is
rather surprising as the DNAJ proteins determine the sub-
strate specificity, and stimulate the activity, of the Hsp70
folding machine and are thus critical nodes in the chaper-
oning network of the cell. Also, most of the Hsp70 and
Hsp90 co-chaperones are not responsive to dnHSF1. For
example, of the 14 Hsp90 co-factors listed in a recent
review [51], only the two AHA1 homologs as well as
STIP1 and, to a lesser extent, ST13 responded strongly to
dnHSF1 (Table 2).
To confirm the effect of HSF1 on the promoter activity
of some of the genes downregulated by dnHSF1, we
isolated the promoters and compared their activities in
HEK-dnHSF1 cells and HEK-cDNA5 cells. The promoters
of the STIP1, ST13, DNAJA1, DNAJB1 (see Table 2), and
PMVK (selected because it is the strongest downregulated
non-chaperone gene; Table 3) genes had significantly
reduced activities in HEK-dnHSF1 cells compared with
Fig. 1 The HSF1 mutants HSF379 and HSF448 have different
effects on basal and heat shock-induced Hsp70 expression. Parental
Flp-In HEK293 cells and HEK293 cells carrying a stably integrated
copy of the pcDNA5-HSF379 (HEK-HSF379) or pcDNA5-HSF448
(HEK-HSF448) plasmid were cultured in the absence or presence of
doxycycline. Cells were exposed to a heat shock (300, 45C),
harvested at the indicated time point (h) after heat shock, and
subjected to western blot analysis using an anti-Hsp70 antibody
Fig. 2 The effects of dnHSF on basal and heat shock-induced
activity of an Hsp70 promoter HEK293 cells carrying a stably
integrated copy of the HSF379 (dnHSF1) were cultured in the absence
(-) or presence (?) of doxycycline. Cells were transfected with a
mixture of the Drosophila melanogaster Hsp70-luciferase reporter
(pHL) and the Renilla Luciferase control plasmid pCMV-RL. At 48 h
after transfection, cells were exposed to a heat shock of 300 at 45C
(HS) or left at 37C (37C). When heat shocked, cells were allowed to
recover for 6 h and harvested. Hsp70 promoter activities were
determined by dividing firefly luciferase values by the corresponding
renilla luciferase (experiments using the HSF448 line) or b-galacto-
sidase (experiments using the dnHSF1 line) values to correct for
varying transfection efficiencies. The relative luciferase activity in
cells cultured at 37C in absence of the various HSF1 mutants was set
at 1. The results are the average of three independent transfections
(standard deviations are indicated by error bars)
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Table 2 Effect of exogenous expression of dnHSF1 on the transcript levels of the members of the families of heat shock proteins and their co-
chaperones
Gene name Acc. no. dnHSF1/Ctrl Alternative name
Ave SD
HSPH family
HSPH1 NM_006644 0.78 0.08 Heat shock 105 kDa/110 kDa protein 1
HSPH2 NM_002154 0.66 0.04 Heat shock 70 kDa protein 4
HSPH3 NM_014278 0.61 0.21 Heat shock 70 kDa protein 4-like
HSPH4 NM_006389 1.19 0.33 Hypoxia up-regulated 1
HSPA family
HSPA1A/Ba NM_005345 0.93 0.18 hsp72
HSPA1L NM_005527 Not on arrayb Not on arrayb Heat shock 70 kDa protein 1-like
HSPA2 NM_021979 1.22 0.20
HSPA5 NM_005347 1.18 0.35 GRP78, BiP
HSPA6 NM_002155 0.46c 0.10 HSP70B0
HSPA8 NM_153201 0.87 0.08 HSC70
HSPA9 NM_004134 0.90 0.08 Mortalin-2 (mitochondrial protein)
HSPA12A NM_025015 1.10 0.20 KIAA0417
HSPA12B NM_052970 ndd ndd
HSPA13 NM_006948 0.57 0.53 STCH
HSPA14 NM_016299 0.85 0.13
HSP90 family
HSP90AA1 NM_005348 0.38 0.06 Hsp90a
HSP90AB1 NM_007355 0.89 0.06 Hsp90b
HSP90B1 NM_003299 1.16 0.36 Grp94
TRAP1 NM_016292 1.06 0.05 TNF receptor-associated protein 1
(mitochondrial Hsp90)
DNAJ (Hsp40) family
DNAJA1 NM_001539 0.64 0.10 HDJ2
DNAJA2 NM_005880 1.30 0.42
DNAJA3 NM_005147 1.00 0.13
DNAJA4 NM_018602 ndd ndd
DNAJB1 NM_006145 0.25 0.05 hsp40
DNAJB2 NM_006736 0.60 0.07 HSJ1
DNAJB3 NM_001001394 ndd ndd
DNAJB4 NM_007034 0.94 0.09
DNAJB5 NM_012266 0.97 0.10
DNAJB6 NM_005494 0.93 0.12
DNAJB7 NM_145174 ndd ndd
DNAJB8 NM_153330 ndd ndd
DNAJB9 NM_012328 1.22 0.17
DNAJB11 NM_016306 1.15 0.39
DNAJB12 NM_001002762 1.04 0.11
DNAJB13 NM_153614 ndd ndd
DNAJB14 NM_024920 0.87 0.04
DNAJC1 NM_022365 1.17 0.23
DNAJC2 NM_014377 0.89 0.06 Zuotin-related factor 1 (ZRF1)
DNAJC3 NM_006260 0.97 0.18
DNAJC4 NM_005528 0.99d 0.10
DNAJC5 NM_025219 ndd ndd Cysteine string protein (CSP)
DNAJC5B NM_033105 ndd ndd Cysteine string protein beta (CSP-beta)
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Table 2 continued
Gene name Acc. no. dnHSF1/Ctrl Alternative name
Ave SD
DNAJC5G NM_173650 1.05c 0.07
DNAJC6 NM_014787 0.87c 0.18
DNAJC7 NM_003315 1.01 0.15
DNAJC8 NM_014280 0.92 0.06
DNAJC9 NM_015190 0.98 0.10
DNAJC10 NM_018981 1.11 0.24
DNAJC11 NM_018198 1.12 0.14
DNAJC12 NM_021800 1.05 0.19
DNAJC13 NM_015268 0.99 0.17
DNAJC14 NM_032364 1.08 0.16
DNAJC15 NM_013238 0.68 0.24
DNAJC16 NM_015291 1.09 0.10
DNAJC17 NM_018163 1.04 0.11
DNAJC18 NM_152686 0.99 0.14
DNAJC19 NM_145261 0.99 0.13
DNAJC20 NM_172002 1.07c 0.12 J-type co-chaperone HSC20 (RP3-366L4.2)
DNAJC21 NM_194283 0.79 0.18 DnaJA5
DNAJC22 NM_024902 1.06 0.08 Hypothetical protein FLJ13236
DNAJC23 NM_007214 0.98 0.08 SEC63
DNAJC24 NM_181706 0.87 0.11 ZCSL3
DNAJC25 NM_001015882 0.99 0.08 DnaJ-like protein (bA16L21.2.1)
DNAJC26 NM_005255 1.07 0.19 Cyclin G associated kinase (GAK)
DNAJC27 NM_016544 0.98 0.10 Ras-associated protein Rap1 (RBJ)
DNAJC28 NM_017833 0.73c 0.18 C21orf55
DNAJC29 NM_014363 0.93 0.04 Sacsin
DNAJC30 NM_032317 1.04 0.06 WBSCR18
HSPB (sHsp) family
HSPB1 NM_001540 0.29 0.13 Hsp27
HSPB2 NM_001541 ndd ndd MKBP
HSPB3 NM_006308 ndd ndd
HSPB4 NM_000394 ndd ndd aA-crystallin (CRYAA)
HSPB5 NM_001885 0.99c 0.18 aB-crystallin (CRYAB)
HSPB6 NM_144617 1.04d 0.25 Hsp20
HSPB7 NM_014424 ndd ndd cvHsp
HSPB8 NM_014365 ndd ndd HSP22
HSPB9 NM_033194 0.68 0.20
HSPB10 NM_024410 ndd ndd ODF1
Others
HSPD1 NM_002156 0.88 0.17 Hsp60, chaperonin
HSPE1 NM_002157 0.73 0.08 Hsp10, chaperonin 10
SERPINH1 NM_001235 0.55 0.08 Hsp47
CCT3 NM_005998 0.67 0.17 TCP1, subunit 3 (gamma)
Co-chaperones
AHSA1 NM_012111 0.63 0.07 AHA1 homolog 1
AHSA2 NM_152392 0.51 0.04 AHA1 homolog 2
BAG1 NM_004323 1.03 0.16
BAG2 NM_004282 1.10 0.13
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control cells, whereas the promoters of the unfolded protein
response target genes CHOP and BiP, two genes with
similar expression levels in HEK-dnHSF1 and control
cells, were not or only slightly affected by dnHSF (Fig. 4).
Note that these promoter activities were measured in
unstressed cells, explaining why the activity of the pro-
moters of the two canonical heat stress-inducible HSPA1A
(Hsp70) gene is only inhibited by about 50%; note also that
the activities of isolated promoter regions do not neces-
sarily reflect the activity of the endogenous promoter which
could also be controlled by chromatin structure and/or
elements lacking from the isolated promoter region. The
HSPB1 gene, for example, has been reported to also have
heat shock elements in its first intron [52].
Lack of heat shock proteins could cause stress in the
cells, which in turn could activate a non-HSF-dependent
stress response (see also [53]). To determine whether
exogenous expression of dnHSF1 caused stress, we
determined whether expression of dnHSF1 is associated
with an increased level of phosphorylated eIF2a. Acti-
vation of eIF2a kinases is a common response to a
variety of stresses (for review, see [54]). As shown in
Fig. 5, the basal level of eIF2a phosphorylation is not
increased by the expression of dnHSF1. In addition, the
decay of eIF2a phosphorylation after a heat shock is not
notably affected by expression of dnHSF1 (Fig. 5). This
is in accordance with previous reports showing that cells
lacking HSF1 are not impaired in their ability to recover
Table 2 continued
Gene name Acc. no. dnHSF1/Ctrl Alternative name
Ave SD
BAG3 NM_004281 1.31 0.18
BAG4 NM_004874 1.28c 0.43
BAG5 NM_001015049 0.99 0.17
PTGES3 NM_006601 0.88 0.14 p23
ST13 NM_003932 0.63 0.08 HIP
STIP1 NM_006819 0.53 0.06 HOP
STUB1 NM_005861 0.97 0.06 CHIP
AIP NM_003977 0.94 0.21
CDC37 NM_007065 ndd ndd
FKBP4 NM_002014 1.00 0.23
FKBP5 NM_004117 0.98 0.07
PPID NM_005038 0.97 0.08 Cyclophilin D
PPP5C NM_006247 1.21 0.30
SGTA NM_003021 1.14 0.24
TOMM70A NM_014820 1.11 0.25
TTC4 NM_004623 1.00 0.04
UNC45A NM_018671 0.99 0.07
a The array oligonucleotides do not discriminate between the transcripts of these two genes
b None of the oligonucleotides on the array hybridize with the transcript of this gene
c The hybridization signal was significant but below 100
d The hybridization signal was not significant
Table 3 Non-chaperone encoding genes downregulated by dnHSF1
Gene name Acc. no. dnHSF1/Ctrl Description
Av. SD
PMVK NM_006556 0.21 0.07 Phosphomevalonate kinase
KLRG1 NM_005810 0.35 0.14 Killer cell lectin-like receptor subfamily G, member 1
CDKL3 NM_016508 0.39 0.17 Cyclin-dependent kinase-like 3
KA21 NM_152349 0.41 0.32 Truncated type I keratin KA21
ZNF473 NM_015428 0.48 0.07 Zinc finger protein 473
MLH1 NM_000249 0.50 0.17 mutL homolog 1
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from heat stress, but do not built up thermostability after
a heat stress [26, 55].
Glucocorticoid signalling is impaired by dnHSF1
and can be rescued by individual co-chaperones
Expression of dnHSF1 depletes the cell of a number of
chaperones and is predicted to decrease the activity of both
the Hsp70 and the Hsp90 folding machine. Both are known
to be important for maturation and function of steroid
hormone receptors (reviewed in [42], [56]) and we thus
examined whether expression of dnHSF1 resulted in
impaired glucocorticoid hormone signaling. A synthetic
glucocorticoid-responsive element (GRE) was linked to a
luciferase reporter and used to monitor the response of
HEK-dnHSF1 and HEK-cDNA5 cells to increasing con-
centrations of dexamethasone. Dexamethasone inducibility
of the GRE was at least 50% inhibited in HEK-dnHSF1
cells compared with HEK-cDNA5 cells (Fig. 6). At
10-6 M dexamethasone, activity of the GRE was induced
by ninefold in HEK-cDNA5 cells and only by fourfold in
HEK-dnHSF1 cells and, at the highest concentration of
dexamethasone, the inducibility in HEK-cDNA5 cells was
even 13-fold compared with only fivefold in HEK-dnHSF1
cells.
If the impaired dexamethasone inducibility in the pres-
ence of dnHSF1 is due to a reduction in the expression
levels of one or more (co-)chaperone genes, then it should
be possible to rescue the glucocorticoid inducibility of the
GRE in HEK-dnHSF1 cells by exogenous expression of
those (co-)chaperones. We therefore tested the effect of
exogeneous expression of different proteins on the gluco-
corticoid response of the pGRE-Luc reporter in HEK-
dnHSF1 cells (Figs. 7 and 8). The chaperone of which the
expression is most affected by dnHSF1 is HSPB1.
Although HSPB1 is not directly involved in the maturation
of the glucocorticoid receptor, its lack may cause over-
loading of part of the folding network of the cell. However,
exogenous expression of HSPB1 or of another sHsp,
HSPB8, had no effect (Fig. 7). The level of Hsp90 is also
affected by dnHSF1 but is apparently not limiting in the
glucocorticoid response, as exogenous expression of Hsp90
was even inhibitory (Fig. 7). PTGES3 (p23) inhibited the
GRE response in HEK-cDNA5 cells (Table 4) as previ-
ously reported [57, 58] but increased it slightly in HEK-
dnHSF1cells. STIP1 (Hop), which is a co-chaperone of
Hsp90 as well as of Hsp70, however, had no effect, either
Fig. 3 Left panel the decay of heat shock protein levels during
expression of dnHSF1. HEK-HSF379 cells were treated with
doxycyclin for the time indicated and harvested. Right panel the
level of heat shock proteins in MEF wild-type cells (?/?) and MEF
cells lacking HSF1 (-/-) either before (-HS) or after heat shock and
recovery (?HS). Cell lysates were subjected to SDS-PAGE and
western blot analysis using the indicated antibodies
Fig. 5 The effect of exogenous expression of dnHSF1 on eIF2a
phosphorylation. HEK-cDNA5 cells and HEK-HSF379 cells were
treated with doxycyclin for 48 h. Cells were then exposed to a heat
shock of 300 at 45C (HS) or left at 37C (37C). When heat shocked,
cells were allowed to recover for the indicated time before harvesting.
Cell lysates were subjected to SDS-PAGE and western blot analysis
using the indicated antibodies
Fig. 4 Inhibition of promoter activity by dnHSF1. Control HEK-
cDNA5 cells and HEK-HSF379 cells were treated with doxycyclin.
After 3 days, cells were transfected with the indicated promoter
reporter constructs (see also ‘‘Materials and methods’’) and a bactin-
bgal reporter. At 48 h after transfection, cells were harvested and
assayed for reporter gene activities. Promoter activities were deter-
mined by dividing luciferase values by the corresponding
b-galactosidase values to correct for varying transfection efficiencies.
The bars correspond to the % activity of the promoter in the HEK-
HSF379 cells compared with the control HEK-cDNA5 cells. The
results are the average of three independent transfections (standard
deviations are indicated by error bars)
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in HEK-cDNA5 (Table 4) or in HEK-dnHSF cells (Fig. 7).
In contrast, ST13 (Hip), an Hsp70 co-chaperone, did
restore dexamethasone inducibility to almost the wild-type
level in HEK-dnHSF cells. Even more effective was
exogenous expression of the Hsp70 co-chaperones
DNAJA1 (HDJ2) or DNAJB1 (Hsp40): this resulted in
even higher dexamethasone inducibility in HEK-dnHSF1
cells compared with HEK-cDNA5 cells (Fig. 7). The res-
cue effect of DNAJA1 and DNAJB1 was not a general
property of Hsp40 family members, since two other
members of the DNAJB family, DNAJB6 and DNAJB8,
did not show any rescue activity (Fig. 7). Expression of
Hsp70 (HSPA1A) itself had no effect (Fig. 7; note that
neither overexpression of DNAJ proteins nor overexpres-
sion of HSPA1A in HEK-cDNA5 cells affected the GRE
response; see Table 4). These data show that it is the pri-
mary folding of the glucocorticoid receptor by the Hsp70
machinery that is most affected in HEK-dnHSF1 cells.
As predicted by the wild-type level of DNAJB1 in
hsf1-/hsf1- MEFs, these cells showed a wild-type glu-
cocorticoid response (data not shown).
Discussion
Comparison of the transcriptome of embryonic fibroblasts
from HSF1 null mice with that of wild-type cells identified
49 genes (19 related to immune response) that were not
upregulated by a heat shock in wild-type cells but never-
theless were expressed at reduced levels in HSF1 null
fibroblasts [27]. When HSF1 was depleted by RNA inter-
ference in HeLa cells, the expression level of 378 genes
changed significantly in the absence of stress [59]. The
main effect, surprisingly, was an increase in expression; for
80% of the affected genes, the transcript level increased. In
contrast, we found no significant increase in expression in
response to dnHSF1; dnHSF1 reduced the expression level
of only 10 genes more than twofold, with a lesser effect on
a number of chaperone encoding genes (Tables 2 and 3).
The difference between the effect of depleting HSF1 in
MEFs and HeLa cells is very likely to be caused by the far
greater dependence of transformed cells on HSF1 [60].
HEK293 are less dependent on HSF1 than HeLa cells [60],
but more so than MEFs. The response to blocking HSF1 in
HEK293 cells might then be expected to be intermediate in
the effect on the transcriptome but it is not. Clearly there is
a difference between depleting HSF1 and expressing a
dominant negative mutant. In part, this difference may be
due to a secondary effect: depletion of HSF1 would free the
chaperones which are usually complexed with HSF1 while
dnHSF1 might capture more chaperones. More importantly
is probably the activity of HSF1 as a repressor of tran-
scription. Recently, it has been shown that HSF1 binds to
MTA1, a co-repressor, to form a complex repressing
estrogen-dependent transcription in breast carcinoma cells
[30]. Similarly, HSF1 has been reported to interact with
C/EBPb, an interaction which represses transcriptional
activation [61]. The loss of HSF1 would release repression;
expression of dnHSF1 could maintain it.
Expression of dnHSF1 is an efficient way of reducing
the chaperoning capacity of the cell, as evidenced by the
loss of the basal glucocorticoid response. Since the
expression of so many genes playing roles at several stages
of glucocorticoid receptor processing was suppressed in
HEK-dnHSF1 cells, we did not expect that overexpression
of individual proteins would rescue the glucocorticoid
response. Nonetheless, the individual co-chaperones
DNAJA1, DNAJB1 and ST13/Hip were able to fully rescue
the dnHSF-mediated inhibition of the glucocorticoid
response; PTGES3/p23 had some effect, whereas over
expression of Hsp90, or STIP1/Hop had no effect. Hsp90
was even inhibitory (Fig. 7). Both DNAJ and ST13/Hop
are co-chaperones of Hsp70 and function in the primary
folding of the glucocorticoid receptor, but at different
levels: DNAJ activates the ATPase of Hsp70, whereas
ST13/Hip stabilizes the Hsp70-ADP state (reviewed
Fig. 6 Exogenous expression of dnHSF1 reduces the glucocorticoid
response. Control HEK-cDNA5 cells and HEK-HSF379 cells were
treated with doxycyclin. After 3 days, cells were transfected with a
glucocorticoid-responsive luciferase reporter (pGRE-Luc) and a
bactin-bgal reporter. At 24 h after transfection, cells were either left
untreated or exposed to the indicated concentrations of dexametha-
sone. At 48 h after transfection, cells were harvested and assayed for
reporter gene activities. Promoter activities were determined by
dividing luciferase values by the corresponding b-galactosidase
values to correct for varying transfection efficiencies. The bars
correspond to the activity of the glucocorticoid-responsive promoter
in the presence of dexamethasone compared to the activity in
untreated cells, which was set at 100%. Gray bars show the results for
control HEK-cDNA5 cells, black bars those for HEK-HSF379 cells.
The results are the average of three independent transfections
(standard deviations are indicated by error bars)
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by [42]). Apparently, overexpression of DNAJA1 or
DNAJB1 can compensate for a shortage of ST13/Hip and
vice versa, as exogenous expression of either protein
restores glucocorticoid sensitivity. Together, these data
show that the limiting node of chaperoning network in
dnHSF1-expressing cells is the Hsp70 folding machine,
which is in turn is limited not by the level of Hsp70 itself
but rather by its co-chaperones. In vitro folding studies of
the glucocorticoid receptor have shown that DNAJB1 is
required in catalytic amounts [62]. Our data also show that
a lack of DNAJB1 can be compensated for by overex-
pression of DNAJA1. Functional redundancy between
Fig. 7 Effect of overexpression of (co-)chaperones on glucocorticoid
signaling in HEK-cDNA5 and HEK-dnHSF1 cells. Control HEK-
cDNA5 cells (light gray bars) and HEK-HSF379 cells (black bars)
were treated with doxycyclin. After 3 days, cells were transfected
with a mixture (4:1:5) of glucocorticoid-responsive luciferase reporter
(pGRE-Luc), a bactin-bgal reporter, and the expression construct
indicated. At 24 h after transfection, cells were either left untreated or
exposed to the indicated concentrations of dexamethasone. At 48 h
after transfection, cells were harvested and assayed for reporter gene
activities. Relative luciferase activities and -fold induction were
determined as described in the legend to Fig. 6. Standard deviations
are indicated by the error bars
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DNAJB1 and another co-chaperone is also implied by the
lack of a phenotype of the DNAJB1 knock-out mouse,
which has only a minor deficiency in acquired thermotol-
erance [63]. In the case of the progesterone receptor, it has
been shown that either DNAJA1 or DNAJB1 can assist in
folding but by distinct mechanisms. DNAJA1 bound
tightly to the progesterone receptor while DNAJB1 did so
only transiently [64].
Heat stress or expression of a dominant-positive HSF1
mutant potentiates the glucocorticoid response [43, 44],
suggesting that the chaperone network is limiting for this
response in normal cells. The chaperone network is also
limiting for luciferase refolding as this can be boosted by
overexpressing Hsp70, an effect which can be blocked by
expressing a dominant-negative DNAJB1 mutant [65]. In
contrast, exogenous expression of single (co-)chaperones
did not enhance the sensitivity of HEK-cDNA cells to
dexamethasone, indicating that, unlike luciferase refolding,
it is either a combination of chaperones and co-chaperones
that is limiting or that other proteins are involved. In
addition, exogenous expression of a dominant negative
DNAJB1 mutant did not significantly block the dexa-
methasone response (data not shown).
Maintaining proteostasis during ageing is expected to
prevent or at least ameliorate age-related protein folding
and inflammatory disease [6, 41]. One possible approach is
Fig. 8 Levels of exogenous expression of (co-)chaperones. Expres-
sion plasmids for the (co-)chaperones indicated on the left were
transfected into either HEK-cDNA cells (control) or HEK-HSF379
cells (?DNA) and expression was induced by adding doxycyclin
(?Dox), except for HSP90AA1, of which expression is constitutive.
Protein levels were determined by western blotting and staining with
the corresponding antibody (see ‘‘Materials and methods’’). The
arrowhead indicates HSPB8. Note that, in the case of DNAJA1,
DNAJB6 and DNAJB8 antibody to the V5-tag carried by the
exogenous proteins was used; the endogenous protein is thus not
detected. b-actin was used as a loading control
b
Table 4 Relative effect of exogenous expression of (co-)chaperones
on glucocorticoid signaling in HEK-cDNA5 cells
Gene name Dexamethasone (nM)
10 100 1,000
(Co-)chaperones/control
HSPB1 1.0 ± 0.1 0.8 ± 0.1 0.9 ± 0.2
HSPB8 0.8 ± 0.1 0.7 ± 0.1 0.8 ± 0.1
HSP90AA1 1.1 ± 0.3 0.9 ± 0.2 0.9 ± 0.3
PTGES3 0.8 ± 0.1 0.7 ± 0.1 0.6 ± 0.1
STIP1 1.0 ± 0.1 0.9 ± 0.1 0.9 ± 0.2
ST13 1.1 ± 0.1 0.9 ± 0.1 1.1 ± 0.2
DNAJA1 1.0 ± 0.1 1.0 ± 0.1 1.1 ± 0.1
DNAJB1 1.0 ± 0.1 1.0 ± 0.1 1.0 ± 0.2
DNAJB6 0.9 ± 0.1 0.8 ± 0.1 0.8 ± 0.1
DNAJB8 0.9 ± 0.2 0.9 ± 0.1 0.8 ± 0.1
HSPA1A 0.8 ± 0.2 0.8 ± 0.2 1.0 ± 0.4
The values represent av. ± SD
4046 L. Heldens et al.
to prevent the decline in HSF1 activity either by targeting
HSF1 directly or by targeting longevity-related factors
which control HSF1 activity such as SIRT1 [38]. One
potential drawback of this approach is that HSF1 also
increases the risk of cancer, another often age-related dis-
ease [60]. An alternative is to maintain the capacity of the
chaperoning network by boosting a single (co-)chaperones.
The results reported here show that DNAJA1 and DNAJB1
are promising targets. The finding that MEF cells do have
wild-type levels of DNAJB1 in the absence of HSF1 shows
that HSF1 can be bypassed in the transcriptional regulation
of the DNAJB1 gene.
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